Table 3. Association of Hepatic Adiponectin Immunoreactivity With Demographic, Metabolic, Histological, and Viral Factors in Patients With Chronic HBV.
Characteristic (n=89) | rsa | P value |
---|---|---|
Gender Male/Female, % | -0.163 | 0.126 |
Age, y | 0.250 | 0.018b |
BMIa, kg/m2 | 0.235 | 0.027b |
ALTa, U/L | 0.111 | 0.300 |
ASTa, U/L | 0.085 | 0.430 |
γ-GTa, U/L | 0.303 | 0.004c |
FPGa, mmol/L | 0.092 | 0.389 |
Insulin, mU/L | -0.232 | 0.028b |
C-Peptide, nmol/L | 0.005 | 0.960 |
Adiponectin, ug/ml | -0.204 | 0.055 |
HOMA-IRa | 0.187 | 0.080 |
Grade of inflammation, % with 0/1/2/3/4 | -0.193 | 0.070 |
Grade of fibrosis, % with 0/1/2/3/4 | -0.252 | 0.017b |
Grade of steatosis, % with 0/1/2/3 | 0.589 | 0.000c |
Viral load, copies/ml | -0.093 | 0.385 |
aAbbreviations: BMI, body mass index; ALT, alanine aminotransferase; AST, aspartateaminotransferase; γ-GT, γ-glutamyltranspeptidase; FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment of insulin resistance.
bP < 0.05
cP < 0.01